Cargando…

Endotracheal Surfactant Combined With Budesonide for Neonatal ARDS

Acute respiratory distress syndrome (ARDS) is a clinical condition characterized by acute diffuse inflammatory lung injury and severe hypoxemia. In 2017, the Montreux Consensus defined diagnostic criteria for ARDS in the neonatal period. The management of ARDS includes strict adherence to lung-prote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deliloglu, Burak, Tuzun, Funda, Cengiz, Merve Meryem, Ozkan, Hasan, Duman, Nuray
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214613/ https://www.ncbi.nlm.nih.gov/pubmed/32432062 http://dx.doi.org/10.3389/fped.2020.00210

Ejemplares similares

Volume Guarantee High-Frequency Oscillatory Ventilation in Preterm Infants With RDS: Tidal Volume and DCO(2) Levels for Optimal Ventilation Using Open-Lung Strategies
por: Tuzun, Funda, et al.
Publicado: (2020)

Pathophysiologically Based Ventilatory Management of Severe Bronchopulmonary Dysplasia
por: Özkan, Hasan, et al.
Publicado: (2022)

Milk kinship hypothesis in light of epigenetic knowledge
por: Ozkan, Hasan, et al.
Publicado: (2012)

Pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome
por: Guo, Hongxing, et al.
Publicado: (2023)

Is European Medicines Agency (EMA) sepsis criteria accurate for neonatal sepsis diagnosis or do we need new criteria?
por: Tuzun, Funda, et al.
Publicado: (2019)

The efficacy of intratracheal administration of surfactant and budesonide combination in the prevention of bronchopulmonary dysplasia
por: Gharehbaghi, Manizheh Mostafa, et al.
Publicado: (2021)

Sonographic Evaluation of the Endotracheal Tube Position in the Neonatal Population: A Comprehensive Review and Meta-Analysis
por: Congedi, Sabrina, et al.
Publicado: (2022)

Epigenetic Programming Through Breast Milk and Its Impact on Milk-Siblings Mating
por: Ozkan, Hasan, et al.
Publicado: (2020)

A Randomized Clinical Trial of Intratracheal Administration of Surfactant and Budesonide Combination in Comparison to Surfactant for Prevention of Bronchopulmonary Dysplasia
por: Gharehbaghi, Manizheh M., et al.
Publicado: (2021)

Aerosol Delivery of Lung Surfactant and Nasal CPAP in the Treatment of Neonatal Respiratory Distress Syndrome
por: Walther, Frans J., et al.
Publicado: (2022)

Comparison of the Effects of Beclomethasone Dipropionate and Budesonide in the Treatment of Children with Mild, Persistent Asthma
por: Bukhari, Ibrahim, et al.
Publicado: (2021)

Editorial: ARDS: Reaching for the Horizon
por: McGuire, John K., et al.
Publicado: (2017)

The Common Haplotype GATGACA in Surfactant-Protein B Gene Is Protective for Respiratory Distress Syndrome in Preterm Neonates
por: Mikolajcikova, Silvia, et al.
Publicado: (2022)

Diagnostic Value of Endotracheal Tube-Aspirate Soluble Triggering Receptor Expressed on Myeloid Cells-1 Concentration for Neonatal Ventilator-Associated Pneumonia
por: Zhou, Jian, et al.
Publicado: (2021)

Biomarkers in Pediatric ARDS: Future Directions
por: Orwoll, Benjamin E., et al.
Publicado: (2016)

Exogenous Surfactant as a Pulmonary Delivery Vehicle for Budesonide In Vivo
por: Baer, Brandon, et al.
Publicado: (2020)

Minimally Invasive Surfactant Administration for the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter Randomized Study in China
por: Han, Tongyan, et al.
Publicado: (2020)

Effect of Nasal Continuous Airway Pressure With and Without Surfactant Administration for the Treatment of Respiratory Distress Syndrome in Preterm Neonates
por: Malibary, Husam, et al.
Publicado: (2023)

Comparison of mortality and short-term outcomes between classic, intubation-surfactant-extubation, and less invasive surfactant administration methods of surfactant replacement therapy
por: Kim, Seung Yeon, et al.
Publicado: (2023)

The Clinical Characteristics of ARDS in Children With Hematological Neoplasms
por: Zhang, Qiao, et al.
Publicado: (2021)

Should Minimally Invasive Surfactant Therapy be a Must in Neonatal Intensive Care Units? Pilot Report of Initial Cases in Dubai
por: Gengaimuthu, Karthikeyan
Publicado: (2018)

FiO(2) Before Surfactant, but Not Time to Surfactant, Affects Outcomes in Infants With Respiratory Distress Syndrome
por: Kruczek, Piotr, et al.
Publicado: (2021)

Intra‐tracheal surfactant/budesonide versus surfactant alone: Comparison of two consecutive cohorts of extremely preterm infants
por: Moschino, Laura, et al.
Publicado: (2021)

Decreased surfactant phosphatidylcholine synthesis in neonates with congenital diaphragmatic hernia during extracorporeal membrane oxygenation
por: Janssen, Daphne J., et al.
Publicado: (2009)

Surfactant therapies for pediatric and neonatal ARDS: ESPNIC expert consensus opinion for future research steps
por: De Luca, Daniele, et al.
Publicado: (2021)

Turkish Neonatal Society guideline on the management of respiratory distress syndrome and surfactant treatment
por: Özkan, Hasan, et al.
Publicado: (2018)

Surfactant-Assisted Distal Pulmonary Distribution of Budesonide Revealed by Mass Spectrometry Imaging
por: Zecchi, Riccardo, et al.
Publicado: (2021)

Prediction of endotracheal tube size in pediatric patients: Development and validation of machine learning models
por: Zhou, Miao, et al.
Publicado: (2022)

Design and Superior Performance of a New Endotracheal Tube to Avoid the Asphyxiation of Premature Infants
por: Walterspiel, Juan N
Publicado: (2023)

Prolonged Glucocorticoid Treatment in ARDS: Impact on Intensive Care Unit-Acquired Weakness
por: Meduri, Gianfranco Umberto, et al.
Publicado: (2016)

Surfactant replacement and open lung concept – Comparison of two treatment strategies in an experimental model of neonatal ARDS
por: Hilgendorff, Anne, et al.
Publicado: (2008)

Plasma Biomarker Analysis in Pediatric ARDS: Generating Future Framework from a Pilot Randomized Control Trial of Methylprednisolone: A Framework for Identifying Plasma Biomarkers Related to Clinical Outcomes in Pediatric ARDS
por: Kimura, Dai, et al.
Publicado: (2016)

Efficacy of Intravenous, Endotracheal, or Nasal Adrenaline Administration During Resuscitation of Near-Term Asphyxiated Lambs
por: Songstad, Nils T., et al.
Publicado: (2020)

Rationale for Prolonged Glucocorticoid Use in Pediatric ARDS: What the Adults Can Teach Us
por: Schwingshackl, Andreas, et al.
Publicado: (2016)

Budesonide/Formoterol Enhances the Expression of Pro Surfactant Protein-B in Lungs of COPD Patients
por: Um, Soo Jung, et al.
Publicado: (2013)

Biophysical and chemical stability of surfactant/budesonide and the pulmonary distribution following intra-tracheal administration
por: Chen, Chung-Ming, et al.
Publicado: (2019)

Blood metabolomics in infants enrolled in a dose escalation pilot trial of budesonide in surfactant
por: Ballard, Philip L., et al.
Publicado: (2021)

Surfactant for the Treatment of ARDS in a Patient With COVID-19
por: Heching, Moshe, et al.
Publicado: (2021)

Reduced levels of pulmonary surfactant in COVID-19 ARDS
por: Schousboe, Peter, et al.
Publicado: (2022)

ENDOTRACHEAL INTUBATION TIMING AND OUTCOME IN ARDS DUE TO COVID-19 INFECTION
por: PEREZ GUTIERREZ, VICTOR, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_seemg91doel5ll4jkjkgkuveh5